admin

Transitions aren’t easy, but sometimes they’re necessary. Could a new leader help steer DocuSign (NASDAQ:DOCU) in the right direction, after the e-signature company seemingly lost its way? The answer remains to be seen, but it’s worthwhile to hold a handful of DOCU stock shares because DocuSign’s comeback could be 2023’s biggest story on Wall Street.
0 Comments
Some of the greatest opportunities can be found in these small-cap stocks to buy. For one, a good number of small-cap stocks are severely undervalued. Two, according to InvestorPlace.com contributor Luke Lango, “Small caps are trading near all-time-low valuations. That’s because investors have been playing defense against a potential recession by buying less-risky large caps.
0 Comments
Shares in SoFi Technologies (NASDAQ:SOFI) have traded sideways over the past month. This is not surprising, given there have not been too many headlines about SOFI stock, since the short-lived excitement surrounding news of insider buying by CEO Anthony Noto. That said, there is something on the horizon that will likely bring this fintech stock
0 Comments
In this episode, Preston and Stig talk about the disruptive new digital currency that’s growing around the world. Bitcoin and other cryptocurrencies could eventual become a popular form of payment without limits across international boarders. This is a fascinating discussion that you won’t want to miss. IN THIS EPISODE, YOU’LL LEARN: – What is Cryptocurrency
0 Comments
We’re going to talk about penny stocks and what is so attractive to these nowadays. There is a couple of reasons why people are attracted to penny stocks, and you need to hear this before you start trading penny stocks. #pennystocks #tradingpenny #tradingstocks #pennystocktrader #cheapstocks Posted at: https://tradersfly.com/blog/why-are-people-attracted-to-penny-stocks/ ? Newsletter & Announcements : https://tradersfly.com/go/tube/ ?
0 Comments
A Biotech Company and an Under-The-Radar Cloud Transformation Stock to Round Out the Year Novavax, Inc. (NVAX) is a biotechnology company engaged in developing innovative vaccines to prevent serious infectious diseases. Novavax’s coronavirus vaccine, NVX-CoV2373, is currently approved for use in the European Union (EU), Indonesia and the Philippines. Regulatory applications seeking approval for the
0 Comments